"Progestins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
| Descriptor ID |
D011372
|
| MeSH Number(s) |
D27.505.696.399.472.858
|
| Concept/Terms |
Progestins- Progestins
- Progestagens
- Progestational Hormones
- Progestogens
- Gestagen
- Progestational Compounds
- Progestagenic Agents
- Gestagenic Agents
- Progestin
- Gestagens
- Progestational Agents
Progestin Effect- Progestin Effect
- Effect, Progestin
- Progestogen Effect
- Effect, Progestogen
- Gestagenic Effects
- Effects, Gestagenic
- Gestagen Effect
- Effect, Gestagen
- Gestagen Effects
- Effects, Gestagen
- Gestagenic Effect
- Effect, Gestagenic
- Progestin Effects
- Effects, Progestin
- Progestogen Effects
- Effects, Progestogen
|
Below are MeSH descriptors whose meaning is more general than "Progestins".
Below are MeSH descriptors whose meaning is more specific than "Progestins".
This graph shows the total number of publications written about "Progestins" by people in this website by year, and whether "Progestins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 2 | 1 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Progestins" by people in Profiles.
-
Hart JM, Macharia A, Modest AM, Johnson KM, Lauring J, Nicasio E, Hacker MR, Spiel MH. Cerclage Plus Adjuvant Vaginal Progesterone for Preterm Birth Prevention in Patients with a Short or Dilated Cervix without Prior Preterm Birth. Am J Perinatol. 2024 Sep; 41(12):1595-1603.
-
Mangione CM, Barry MJ, Nicholson WK, Cabana M, Caughey AB, Chelmow D, Coker TR, Davis EM, Donahue KE, Ja?n CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. JAMA. 2022 11 01; 328(17):1740-1746.
-
Schoretsanitis G, Deligiannidis KM, Paulzen M, Spina E, de Leon J. Drug-drug interactions between psychotropic medications and oral contraceptives. Expert Opin Drug Metab Toxicol. 2022 Jun; 18(6):395-411.
-
Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial. Am J Obstet Gynecol. 2022 05; 226(5):722.e1-722.e12.
-
Young CH, Snow B, DeVore SB, Mohandass A, Nemmara VV, Thompson PR, Thyagarajan B, Navratil AM, Cherrington BD. Progesterone stimulates histone citrullination to increase IGFBP1 expression in uterine cells. Reproduction. 2021 07 08; 162(2):117-127.
-
Weatherborn M, Mesiano S. Rationale for current and future progestin-based therapies to prevent preterm birth. Best Pract Res Clin Obstet Gynaecol. 2018 Oct; 52:114-125.
-
Gass M, Larson J, Cochrane B, Manson JE, Lane D, Barnabei V, Ockene J, Stefanick ML, Mouton C. Sexual activity and vaginal symptoms in the postintervention phase of the Women's Health Initiative Hormone Therapy Trials. Menopause. 2018 03; 25(3):252-264.
-
Saccone G, Schoen C, Franasiak JM, Scott RT, Berghella V. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials. Fertil Steril. 2017 02; 107(2):430-438.e3.
-
Schoen CN, Tabbah S, Iams JD, Caughey AB, Berghella V. Why the United States preterm birth rate is declining. Am J Obstet Gynecol. 2015 Aug; 213(2):175-80.
-
Lima-Hern?ndez FJ, G?mora-Arrati P, Garc?a-Ju?rez M, Blaustein JD, Etgen AM, Beyer C, Gonz?lez-Flores O. Estrogen receptors regulate the estrous behavior induced by progestins, peptides, and prostaglandin E2. Horm Behav. 2014 Jul; 66(2):361-8.